Olanzapine treatment decreases the density of muscarinic M2 receptors in the dorsal vagal complex of rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 4, 2007, Pages 915-920

  Deng, Chao ^a,b   Weston Green, Katrina L ^a,b   Han, Mei ^a,b   Huang, Xu Feng ^a,b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b Neuroscience Institute of Schizophrenia and Allied Disorders   (Australia)

Author keywords

Antipsychotics; Brainstem; Muscarinic receptor; Receptor binding; Weight gain

Indexed keywords

HALOPERIDOL; MUSCARINIC M2 RECEPTOR; N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; OLANZAPINE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HYPOGLOSSAL NUCLEUS; NEUROPHARMACOLOGY; NEUROTRANSMISSION; NONHUMAN; PHARMACODYNAMICS; QUANTITATIVE ANALYSIS; RAT; RECEPTOR DENSITY; VAGUS NERVE DORSAL NUCLEUS; WEIGHT GAIN;

ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BENZODIAZEPINES; BINDING, COMPETITIVE; FEMALE; GENE EXPRESSION REGULATION; MEDULLA OBLONGATA; PARASYMPATHOLYTICS; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; TRITIUM; WEIGHT GAIN;

EID: 34247524110     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.02.009     Document Type: Article

References (36)

1. Allison D.B., Mentore J.L., Heo M., Chandler L.P., Cappelleri J.C., Infante M.C., et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156 (1999) 1686-1696
2. Aravagiri M., Teper Y., and Marder S.R. Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm. Drug Dispos. 20 (1999) 369-377
3. Arjona A.A., Zhang S.X., Adamson B., and Wurtman R.J. An animal model of antipsychotic-induced weight gain. Behav Brain Res 152 (2004) 121-127
4. Buijs R.M., Chun S.J., Niijima A., Romijn H.J., and Nagai K. Parasympathetic and sympathetic control of the pancreas: a role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake. J Comp Neurol 431 (2001) 405-423
5. Bymaster F.P., Nelson D.L., DeLapp N.W., Falcone J.F., Eckols K., Truex L.L., et al. Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro. Schizophr Res 37 (1999) 107-122
6. Bymaster F.P., Felder C.C., Tzavara E., Nomikos G.G., Calligaro D.O., and McKinzie D.L. Muscarinic mechanisms of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 1125-1143
7. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat Neurosci 8 (2005) 571-578
8. Cooper G.D., Pickavance L.C., Wilding J.P., Halford J.C., and Goudie A.J. A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology 181 (2005) 80-89
9. Cooper G.D., Pickavance L.C., Wilding J.P., Harrold J.A., Halford G., and Goudie A.J. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities. J Psychopharmacol 18 (2006) Online First:first published on October. doi:10.1177/0269881106069637
10. Deng C., and Huang X.F. Decreased density of muscarinic receptors in the superior temporal gyrus in schizophrenia. J Neurosci Res 81 (2005) 883-890
11. Dorje F., Wess J., Lambrecht G., Tacke R., Mutschler E., and Brann M.R. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256 (1991) 727-733
12. Douglas C.L., Baghdoyan H.A., and Lydic R. M2 muscarinic autoreceptors modulate acetylcholine release in prefrontal cortex of C57BL/6J mouse. J Pharmacol Exp Ther 299 (2001) 960-966
13. Eder U., Mangweth B., Ebenbichler C., Weiss E., Hofer A., Hummer M., et al. Association of olanzapine-induced weight gain with an increase in body fat. Am J Psychiatry 158 (2001) 1719-1722
14. Fadel J., Bubser M., and Deutch A.Y. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J Neurosci 22 (2002) 6742-6746
15. Goudie A.J., Smith J.A., Robertson A., and Cavanagh C. Clozapine as a drug of dependence. Psychopharmacology 142 (1999) 369-374
16. Goudie A.J., Smith J.A., and Halford J.C. Characterization of olanzapine-induced weight gain in rats. J Psychopharmacol 16 (2002) 291-296
17. Grill H.J., Schwartz M.W., Kaplan J.M., Foxhall J.S., Breininger J., and Baskin D.G. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology 143 (2002) 239-246
18. Huang X.-F., Deng C., and Zavitsanou K. Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats. Neuropeptides 40 (2006) 213-219
19. Huang X.-F., Han M., Huang X., Zavitsanou K., and Deng C. Olanzapine differentially affects 5-HT2A and 2C receptor mRNA expression in the rat brain. Behav Brain Res 171 (2006) 355-362
20. Kalinichev M., Rourke C., Daniels A.J., Grizzle M.K., Britt C.S., Ignar D.M., et al. Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats. Psychopharmacology 182 (2005) 220-231
21. Kapur S., Wadenberg M.L., and Remington G. Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench. [see comment]. Can J Psychiatry 45 (2000) 241-246
22. Kroeze W.K., Hufeisen S.J., Popadak B.A., Renock S.M., Steinberg S., Ernsberger P., et al. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28 (2003) 519-526
23. Levey A.I. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 52 (1993) 441-448
24. Levey A.I., Edmunds S.M., Hersch S.M., Wiley R.G., and Heilman C.J. Light and electron microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of the rat. J Comp Neurol 351 (1995) 339-356
25. Mallios V.J., Lydic R., and Baghdoyan H.A. Muscarinic receptor subtypes are differentially distributed across brain stem respiratory nuclei. Am J Physiol 268 (1995) L941-L949
26. Matsui-Sakata A., Ohtani H., and Sawada Y. Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. Drug Metab Pharmacokinet 20 (2005) 368-378
27. Mrzljak L., Levey A.I., and Rakic P. Selective expression of m2 muscarinic receptor in the parvocellular channel of the primate visual cortex. Proc Natl Acad Sci U S A 93 (1996) 7337-7340
28. Nasrallah H. A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 1 (2003) 83-96
29. Nayudu S.K., and Scheftner W.A. Case report of withdrawal syndrome after olanzapine discontinuation. J Clin Psychopharmacol 20 (2000) 489-490
30. Oda S., Kuroda M., Kakuta S., and Kishi K. Differential immunolocalization of m2 and m3 muscarinic receptors in the anteroventral and anterodorsal thalamic nuclei of the rat. Brain Res 894 (2001) 109-120
31. Pagnotta S.E., Lape R., Quitadamo C., and Nistri A. Pre- and postsynaptic modulation of glycinergic and gabaergic transmission by muscarinic receptors on rat hypoglossal motoneurons in vitro. Neuroscience 130 (2005) 783-795
32. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd edition (1997), Academic Press, San Diego
33. Pouzet B., Mow T., Kreilgaard M., and Velschow S. Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human. Pharmacol Biochem Behav 75 (2003) 133-140
34. Richelson E., and Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 68 (2000) 29-39
35. Schwartz G.J. The role of gastrointestinal vagal afferents in the control of food intake: current prospects. Nutrition 16 (2000) 866-873
36. Terry Jr. A.V., Gearhart D.A., Mahadik S.P., Warsi S., and Waller J.L. Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain. Neuroscience 140 (2006) 1277-1287